Log in
Enquire now
‌

US Patent 8404681 Xanthones, thioxanthones and acridinones as DNA-PK inhibitors

Patent 8404681 was granted and assigned to Luitpold Pharmaceuticals on March, 2013 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Patent abstractTimelineTable: Further ResourcesReferences
Is a
Patent
Patent

Patent attributes

Current Assignee
‌
Luitpold Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8404681
Date of Patent
March 26, 2013
Patent Application Number
10550978
Date Filed
March 19, 2004
Patent Citations Received
‌
US Patent 12121524 DNA-PK inhibitors
3
‌
US Patent 12005127 DNA-PK inhibitors
4
Patent Primary Examiner
‌
Rebecca Anderson
Patent abstract

Compound that inhibit DNA-dependent protein kinase, compositions comprising the compounds, methods of inhibiting the DNA-PK biological activity, methods of sensitizing cells the agents that cause DNA lesions, and methods of potentiating cancer treatment are disclosed.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8404681 Xanthones, thioxanthones and acridinones as DNA-PK inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.